Current Research

Interventions that delay aging have been correlated with improved maintenance of cellular components and cellular homeostasis [1]. Consequently, aging research has been heavily focused on studying the protective and homeostatic mechanisms within cells. However, cells are surrounded by extracellular matrices (ECM) and components of the ECM become fragmented, damaged, modified and cross-linked during aging [2-8]; thereby potentially impairing cellular functions and intercellular communications, which are major hallmarks of aging [9].

In our previous research, sponsored in part by the Swiss National Science Foundation, we established the first insight into the importance of the ECM for healthy aging during longevity in C. elegans (Ewald et al., Nature 2015). We discovered that almost all longevity-promoting interventions enhance ECM gene expression and this ECM enhancement is essential and sufficient for delaying aging [10]. Furthermore, we uncovered tantalizing evidence for conservation of such an ECM gene expression enhancement in mice using published expression profiles [10]. Interestingly, long-lived mice have been characterized by a prolonged preservation of ECM integrity [11,12], suggesting that longevity interventions might also protect or maintain extracellular components through as yet unknown mechanisms.

Although numerous studies have pointed to a progressive decline in ECM integrity during aging, studying the in vivo role of ECM homeostasis during aging in mammals is complicated and is virtually unexplored in any organism. The model organism C. elegans provides unique opportunities to explore ECM integrity during aging, since: 1) C. elegans is transparent thereby allowing ECM components to be tagged by fluorescent proteins to directly monitor ECM homeostasis and integrity non-invasively in vivo; and 2) C. elegans is a well-established aging model because of its short lifespan and powerful genetics. For these reasons, using C. elegans is an innovative approach that enables us to gain insights into the mechanisms underlying how enhanced ECM gene expression extends healthspan, which remains unknown. Furthermore, our previous research suggests an exciting hypothesis of an active and probably conserved process (ECM gene expression enhancement) initiated by many longevity interventions. To address this hypothesis, we will address the following specific aims:

  1. Characterize the pro-longevity transcriptional program initiated by ECM enhancement.
  2. Determine which cellular effects of ECM enhance